Mary Cushman: The Role of IL-6 in Cardiovascular Disease
Mary Cushman, University Distinguished Professor and Vice Chair at the University of Vermont, shared a post on LinkedIn, about a recent article she and her colleagues co-authored, published in JACC Journals, adding:
“Love this collaborative paper I helped with on interleukin-6 and CVD related outcomes.
IL-6 is a robust predictor overall & among various subgroups, even adding to CRP effects.
Is it time for a reliable automated IL-6 assay?”
Title: The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC)
Authors: Zhiqi Yao, Zeina A. Dardari, Michael J. LaMonte, Kunihiro Matsushita, Christie M. Ballantyne, Joao A. Lima, Ramachandran S. Vasan, Eleanor M. Simonsick, Lawrence J. Appel, Debbie L. Cohen, Suzanne Judd, Peggy M. Cawthon, Amil M. Shah, Brittany N. Weber, Tianyu Cao, Omar Dzaye, Erfan Tasdighi, Yara Jelwan, Kunal K. Jha, Bruce M. Psaty, Joshua C. Bis, Nels C. Olson, James P. Lash, Mary Cushman, Charles B. Eaton, and Michael J. Blaha
Other posts featuring Mary Cushman on Hemostasis Today.
-
Aug 26, 2026, 10:09Gemma Figtree: How Well Do We Predict Heart Attack Risk in Women?
-
Aug 26, 2026, 10:06Understanding and Managing Fatigue in ITP – ITP Support Association
-
Aug 26, 2026, 10:04Abdul Muqtadir Abbasi: When a High INR Hides a Thrombotic Cancer
-
Aug 26, 2026, 09:42Mohammed Alo: What’s Wrong With the New Blood Pressure Guidelines?
-
Aug 26, 2026, 07:49Linda Koch: Understanding Ageing Through Biological Transitions
-
Aug 26, 2026, 05:38Elias Lee։ Beyond MCA Stenosis – Recognizing Moyamoya
-
Aug 26, 2026, 03:46Hugo Ribeiro: Which NSAIDs Are Safest for Older Adults?
-
Aug 25, 2026, 19:45Cara T. Hoepner: Omega-3 is Not an Exposure
-
Aug 25, 2026, 19:42Mark Skinner Honored With the Lifetime Achievement Award – National Bleeding Disorders Foundation